🇺🇸 FDA
Pipeline program

Dexamethasone

KC/KE-22-0022/FR-4

Phase 2 small_molecule active

Quick answer

Dexamethasone for Voice Change is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Voice Change
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials